重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
4期
439-441,445
,共4页
杨简%范致星%李馨欣%彭家芹%姜玉蓉%陈勇
楊簡%範緻星%李馨訢%彭傢芹%薑玉蓉%陳勇
양간%범치성%리형흔%팽가근%강옥용%진용
Toll样受体4%高迁移率蛋白B1%PI3K/Akt信号通路%血管平滑肌细胞
Toll樣受體4%高遷移率蛋白B1%PI3K/Akt信號通路%血管平滑肌細胞
Toll양수체4%고천이솔단백B1%PI3K/Akt신호통로%혈관평활기세포
Toll-like receptor 4%high mobility group box-1%PI3K/Akt pathway%vascular smooth muscle cells
目的:探讨高迁移率蛋白B1(HMGB1)对血管平滑肌细胞(VSMCs)迁移的影响及 TLR4依赖的 TLR4/PI3K/Akt信号通路介导的分子机制。方法体外分离培养大鼠胸主动脉VSMCs ,采用不同浓度 HMGB1(0.1~1000.0 ng /mL)处理,分为对照组(未经任何处理)、HMGB1组、HMGB1+ TLR4 siRNA转染组、Control siRNA转染组和磷脂酰肌醇3‐激酶(PI3K)抑制剂(LY294002)干预组,观察各组细胞活性及 HMGB1对 VSMCs 迁移的影响;实时定量 RT‐PCR与 Western blot 分别检测TLR4、Akt、p‐Akt、PI3K mRNA和蛋白的表达;ELISA测定PI3K的活性。结果 HMGB1(0.1~1000.0 ng/mL)呈剂量依赖性促进VSMCs迁移(P< 0.05);经细胞活性测定,HMGB1在使用的浓度范围内对 VSMCs未造成细胞毒性作用(P< 0.05);HMGB1(100 ng/mL)处理的 VSMCs细胞组 PI3K 活性及 Akt磷酸化水平明显增加(P< 0.05);经 TLR4 siRNA 转染发现, HMGB1引起的VSMCs迁移明显减弱(P<0.05),同样在PI3k抑制剂干预组,PI3K/Akt途径活化和HMGB1介导的VSMCs迁移也被明显抑制(P<0.05)。结论 HMGB1呈剂量依赖性促进VSMCs迁移,TLR4依赖的 TLR4/PI3K/Akt信号通路参与了此过程,提示以TLR4依赖的PI3K/Akt途径为靶点,可为阻塞性血管疾病的治疗提供新思路。
目的:探討高遷移率蛋白B1(HMGB1)對血管平滑肌細胞(VSMCs)遷移的影響及 TLR4依賴的 TLR4/PI3K/Akt信號通路介導的分子機製。方法體外分離培養大鼠胸主動脈VSMCs ,採用不同濃度 HMGB1(0.1~1000.0 ng /mL)處理,分為對照組(未經任何處理)、HMGB1組、HMGB1+ TLR4 siRNA轉染組、Control siRNA轉染組和燐脂酰肌醇3‐激酶(PI3K)抑製劑(LY294002)榦預組,觀察各組細胞活性及 HMGB1對 VSMCs 遷移的影響;實時定量 RT‐PCR與 Western blot 分彆檢測TLR4、Akt、p‐Akt、PI3K mRNA和蛋白的錶達;ELISA測定PI3K的活性。結果 HMGB1(0.1~1000.0 ng/mL)呈劑量依賴性促進VSMCs遷移(P< 0.05);經細胞活性測定,HMGB1在使用的濃度範圍內對 VSMCs未造成細胞毒性作用(P< 0.05);HMGB1(100 ng/mL)處理的 VSMCs細胞組 PI3K 活性及 Akt燐痠化水平明顯增加(P< 0.05);經 TLR4 siRNA 轉染髮現, HMGB1引起的VSMCs遷移明顯減弱(P<0.05),同樣在PI3k抑製劑榦預組,PI3K/Akt途徑活化和HMGB1介導的VSMCs遷移也被明顯抑製(P<0.05)。結論 HMGB1呈劑量依賴性促進VSMCs遷移,TLR4依賴的 TLR4/PI3K/Akt信號通路參與瞭此過程,提示以TLR4依賴的PI3K/Akt途徑為靶點,可為阻塞性血管疾病的治療提供新思路。
목적:탐토고천이솔단백B1(HMGB1)대혈관평활기세포(VSMCs)천이적영향급 TLR4의뢰적 TLR4/PI3K/Akt신호통로개도적분자궤제。방법체외분리배양대서흉주동맥VSMCs ,채용불동농도 HMGB1(0.1~1000.0 ng /mL)처리,분위대조조(미경임하처리)、HMGB1조、HMGB1+ TLR4 siRNA전염조、Control siRNA전염조화린지선기순3‐격매(PI3K)억제제(LY294002)간예조,관찰각조세포활성급 HMGB1대 VSMCs 천이적영향;실시정량 RT‐PCR여 Western blot 분별검측TLR4、Akt、p‐Akt、PI3K mRNA화단백적표체;ELISA측정PI3K적활성。결과 HMGB1(0.1~1000.0 ng/mL)정제량의뢰성촉진VSMCs천이(P< 0.05);경세포활성측정,HMGB1재사용적농도범위내대 VSMCs미조성세포독성작용(P< 0.05);HMGB1(100 ng/mL)처리적 VSMCs세포조 PI3K 활성급 Akt린산화수평명현증가(P< 0.05);경 TLR4 siRNA 전염발현, HMGB1인기적VSMCs천이명현감약(P<0.05),동양재PI3k억제제간예조,PI3K/Akt도경활화화HMGB1개도적VSMCs천이야피명현억제(P<0.05)。결론 HMGB1정제량의뢰성촉진VSMCs천이,TLR4의뢰적 TLR4/PI3K/Akt신호통로삼여료차과정,제시이TLR4의뢰적PI3K/Akt도경위파점,가위조새성혈관질병적치료제공신사로。
Objective To investigate the effect of high mobility group box‐1(HMGB1) on the migration of vascular smooth cells (VSMCs) and the role of TLR4‐dependent PI3K/Akt pathway in the process .Methods Primary VSMCs were isolated from the thoracic aorta of male SD rats and cultured in vitro .Control group ,TLR4 siRNA transfected group ,control siRNA transfected group and PI3k inhibitor (LY294002) intervention group were stimulated by HMGB1 (0 .1-1 000 .0 ng/mL) .Expression of TLR4 mRNA was detected by RT‐PCR ,protein expression of TLR4 ,Akt ,pAkt ,PI3K were detected by Western blot .Activity of the im‐munoprecipitated PI3K enzyme was assessed in a competitive ELISA .The migration and cell viability of every groups were ob‐served .Results HMGB1 (0 .1 -1 000 .0 ng/mL) stimulated VSMCs migration in a dose‐dependent manner and incubation of VSMCs with 100 ng/mL caused a rapid migration (P< 0 .05) .At the concentrations used ,HMGB1 did not cause any cytotoxic effects (P<0 .05) .Migration of VSMCs toward HMGB1 was significantly inhibited by silencing of TLR4 (P<0 .05) .Pretreated cells with TLR4 siRNA or the PI3K inhibitor LY294002 could markedly block PI3K/Akt pathway activation and VSMCs migration mediated by HMGB1 (both P<0 .05) .Conclusion HMGB1 stimulated VSMCs migration in a dose‐dependent manner and TLR4‐dependent PI3K/Akt signaling pathway played an important role in the migration of VSMCs mediated by HMGB1 .This research indicates that TLR4‐dependent TLR4/PI3K/Akt signaling pathway could be the target in the treatment of obstructive cardiovascu‐lar disease .